scholarly journals Using communications to promote momentum toward tobacco endgame

2021 ◽  
Vol 19 (December) ◽  
pp. 1-3
Author(s):  
Megan Arendt ◽  
Shana Bedi ◽  
Isabella Costanzo ◽  
Saoimanu Sope
Keyword(s):  
2017 ◽  
Vol 3 (1) ◽  
pp. 56-67
Author(s):  
Jude Ball ◽  
Richard Edwards ◽  
Andrew Waa ◽  
El-Shadan Tautolo

2018 ◽  
Vol 28 (6) ◽  
pp. 643-650 ◽  
Author(s):  
Frederieke S Petrović-van der Deen ◽  
Tony Blakely ◽  
Giorgi Kvizhinadze ◽  
Christine L Cleghorn ◽  
Linda J Cobiac ◽  
...  

ObjectiveRestricting tobacco sales to pharmacies only, including the provision of cessation advice, has been suggested as a potential measure to hasten progress towards the tobacco endgame. We aimed to quantify the impacts of this hypothetical intervention package on future smoking prevalence, population health and health system costs for a country with an endgame goal: New Zealand (NZ).MethodsWe used two peer-reviewed simulation models: 1) a dynamic population forecasting model for smoking prevalence and 2) a closed cohort multi-state life-table model for future health gains and costs by sex, age and ethnicity. Greater costs due to increased travel distances to purchase tobacco were treated as an increase in the price of tobacco. Annual cessation rates were multiplied with the effect size for brief opportunistic cessation advice on sustained smoking abstinence.ResultsThe intervention package was associated with a reduction in future smoking prevalence, such that by 2025 prevalence was 17.3%/6.8% for Māori (Indigenous)/non-Māori compared to 20.5%/8.1% projected under no intervention. The measure was furthermore estimated to accrue 41 700 discounted quality-adjusted life-years (QALYs) (95% uncertainty interval (UI): 33 500 to 51 600) over the remainder of the 2011 NZ population’s lives. Of these QALYs gained, 74% were due to the provision of cessation advice over and above the limiting of sales to pharmacies.ConclusionsThis work provides modelling-level evidence that the package of restricting tobacco sales to only pharmacies combined with cessation advice in these settings can accelerate progress towards the tobacco endgame, and achieve large population health benefits and cost-savings.


PLoS Medicine ◽  
2015 ◽  
Vol 12 (5) ◽  
pp. e1001832 ◽  
Author(s):  
Thomas E. Novotny
Keyword(s):  

CMAJ Open ◽  
2018 ◽  
Vol 6 (3) ◽  
pp. E412-E422 ◽  
Author(s):  
Janet Chung-Hall ◽  
Geoffrey T. Fong ◽  
Pete Driezen ◽  
Lorraine Craig

2020 ◽  
Vol 40 (2) ◽  
pp. 250-265
Author(s):  
Shelagh Ferguson ◽  
Jan Brace-Govan ◽  
Janet Hoek ◽  
Matthew Mulconroy

As more countries set smoking endgame goals and introduce measures to denormalize smoking, smokers’ experience of stigma may intensify and require new management strategies. Probing the tension between environmental changes that support population-level behaviour change and individuals’ sense making, which occurs at a micro, everyday level, provides unique insights into reactance, agency and stigma. Using a Foucauldian informed approach, we analyze how young RYO (roll-your-own tobacco) smokers internalize neoliberal marketplace economic norms and create positions of resistance. Experience-based videographies and in-depth interviews with 15 New Zealand young adults aged 20-30 illustrate how participants resist stigma and the social disapproval they experience. This analysis identifies how smoking denormalization affects practices and pleasures, and generates four discernible positions of resistance: Socialized, Comfort, Status and Pleasure Orientated Resistances. These highlight intersections between policy initiatives and consumer resistance, offering new insights relevant to public policy.


2014 ◽  
Vol 370 (4) ◽  
pp. 293-295 ◽  
Author(s):  
Amy L. Fairchild ◽  
Ronald Bayer ◽  
James Colgrove
Keyword(s):  

2020 ◽  
pp. tobaccocontrol-2020-055722 ◽  
Author(s):  
Amanda Y. Kong ◽  
Brian A. King

Much of the progress in reducing cigarette smoking and tobacco-related morbidity and mortality among youth and adults is attributable to population-level strategies previously described in the context of the Tobacco Control Vaccine. The retail environment is used heavily by the tobacco industry to promote and advertise its products, and variations in exposure to and characteristics of the retail environment exist across demographic groups. It is therefore also an essential environment for further reducing smoking, as well as ameliorating racial, ethnic and socioeconomic tobacco-related disparities. This commentary provides an overview of the importance of incorporating strategies focused on the tobacco retailer environment (availability; pricing and promotion; advertising and display; age of sale; and retail licensure) as part of a comprehensive approach to tobacco prevention and control. To reach tobacco endgame targets, such innovative strategies are a complement to, but not a replacement for, long-standing evidence-based components of the Tobacco Control Vaccine.


Sign in / Sign up

Export Citation Format

Share Document